Subscribe to The NIH Catalyst Newsletter and receive email updates.
Share a photo, image, quote, or "letter to the editor" for publication and yours could be chosen for the next issue.
BY MARK ROLTSCH, NHLBI
The Exercise Interest Group (EIG) provides a forum in which researchers, clinicians, and other interested persons from NIH and the extramural community can explore and promote epidemiological, clinical, and basic research on the effects of exercise in prevention and treatment of disease and disability. The EIG’s goals include stimulating inter-institute collaborations to develop innovative research programs and initiatives investigating the effects of habitual exercise; stimulating interest in the outside scientific community to submit research applications to NIH to investigate the effects of exercise in prevention and treatment of disease and disability; maintaining an up-to-date list of experts in exercise science to serve as potential NIH study-section members and ad hoc grant reviewers; providing a forum for outside organizations with expertise in exercise science to provide input and feedback to NIH about important issues in this area; and providing a forum for developing educational programs and lectures in exercise science in the metropolitan Washington, D.C., area. The next meeting will be Wednesday, May 16, 1:00–2:00 p.m., Room 5185, Neuroscience Center, 6001 Executive Boulevard, Bethesda, Md. For more information about the SIG or the meeting, visit http://sigs.nih.gov/exercise or contact Mark Roltsch (email@example.com or 301-435-0535).
BY CARRIE LAURENCOT, NCI
The Regulatory Affairs for Clinical Development (RACD) interest group aims to expedite clinical development by providing accessible information on regulatory expectations during the development of clinical products. The group provides fellowship and education to those interested in navigating the complex regulatory requirements for the development of investigational agents and devices. The RACD interest group hopes to attract members of clinical–development teams including those involved in the chemistry and manufacturing processes, nonclinical in vitro and in vivo studies (including investigational-new-drug-directed pharmacology and toxicology studies), clinical studies, statistics, data management, regulatory affairs, and protection of human subjects in research. NIH intramural and extramural scientists, as well as staff at FDA and other federal agencies are welcome. The inaugural meeting will be held on Tuesday, May 22, 2012, 11:30 a.m.–12:30 p.m., in Building 10, Room 3-3750. Dinora Dominguez will give a presentation about ResearchMatch (http://www.researchmatch.org), a registry of volunteers who wish to participate in research studies. For more information and notices of meetings and events, join the LISTSERV (https://list.nih.gov/cgi-bin/wa.exe?SUBED1=RACD-L&A=1); visit the Web site (http://sigs.nih.gov/RACD/Pages/default.aspx); or contact the group moderator Carrie Laurencot (firstname.lastname@example.org).
For a complete SIG list, go to http://www.nih.gov/sigs